Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma is a research paper published in Molecular Therapy — Oncolytics (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA195764
National Institutes of Health
Grant: CA210964
National Institutes of Health
Grant: CA234324
National Cancer Institute
Grant: CA090628
NCI NIH HHS
Grant: K01 CA234324
NCI NIH HHS
Grant: DP2 CA195764
NCI NIH HHS
Grant: P50 CA210964
NCI NIH HHS
Grant: K12 CA090628
National Institutes of Health
Grant: 1DP2CA195764-01
Oncolytic Virotherapy in Hepatocellular Cancer
National Institutes of Health
Grant: 5K12CA090628-25
Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic
National Institutes of Health
Grant: 7K01CA234324-04
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
Mayo Clinic
The Kemper & Ethel Marley Foundation
University of Arkansas for Medical Sciences
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
AstraZeneca
Department of Molecular Medicine, University of Pavia
G1 Therapeutics
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals